Insulet (PODD) Receivables (2010 - 2026)
Insulet's (PODD) quarterly Receivables came in at $544.7 million in Q1 2026, up 92.41% YoY from $283.1 million in Q1 2025, and up 5.38% on a QoQ basis from $516.9 million in Q4 2025.
Insulet (PODD) Receivables (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Receivables data on file, last reported at $544.7 million in Q1 2026.
- Quarterly Receivables rose 92.41% year-over-year to $544.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $544.7 million (up 92.41% YoY) and the FY2025 annual result came in at $516.9 million, up 357.43% from the prior year.
- Receivables grew to $544.7 million in Q1 2026, from $516.9 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $544.7 million in Q1 2026 to a low of $5.8 million in Q4 2023.
- A 5-year average of $245.1 million and a median of $217.2 million in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables slumped 97.18% — and 2024, when it soared 1848.28%.
- Tracing PODD's Receivables over 5 years: stood at $205.6 million in 2022, then tumbled by 97.18% to $5.8 million in 2023, then soared by 1848.28% to $113.0 million in 2024, then jumped by 357.43% to $516.9 million in 2025, then rose by 5.38% to $544.7 million in 2026.
- The last three Receivables figures came in at $544.7 million (Q1 2026), $516.9 million (Q4 2025), and $306.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Insulet | 10.36 Bn | 9.82 Bn | 562.60 Mn | 588.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 588.70 Mn |
| Mar 31, 2026 | 544.70 Mn |
| Dec 31, 2025 | 516.90 Mn |
| Sep 30, 2025 | 306.50 Mn |
| Jun 30, 2025 | 292.60 Mn |
| Mar 31, 2025 | 283.10 Mn |
| Dec 31, 2024 | 113.00 Mn |
| Sep 30, 2024 | 261.70 Mn |
| Jun 30, 2024 | 242.60 Mn |
| Mar 31, 2024 | 234.10 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 190.40 Mn |
| Jun 30, 2023 | 154.60 Mn |
| Mar 31, 2023 | 217.20 Mn |
| Dec 31, 2022 | 205.60 Mn |
| Sep 30, 2022 | 201.40 Mn |
| Jun 30, 2022 | 206.60 Mn |
| Mar 31, 2022 | 189.30 Mn |
| Dec 31, 2021 | 161.00 Mn |
| Sep 30, 2021 | 130.40 Mn |